Olympus Corp (STU:OLY1)
€ 14.77 -0.035 (-0.24%) Market Cap: 16.80 Bil Enterprise Value: 16.61 Bil PE Ratio: 37.94 PB Ratio: 4.10 GF Score: 89/100

Olympus Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / NTS GMT
Release Date Price: €18.91 (-2.35%)
Yasuo Takeuchi
Olympus Corporation - President, CEO, Representative Executive Officer & Director

Hello, everyone. I am Yasuo Takeuchi, CEO of Olympus Corporation. I am privileged to be invited again to present our story at this conference. We are excited to share our plans with you as we look to a new horizon.

Here is the agenda for today. As you know, in 2019, Olympus embarked on an ambitious transformation journey. We are now focused on our Medical Business, and as our recent results show, we are making steady progress towards achieving the KPIs we outlined in our corporate strategy, but the industry arena of which we were now a part is also undergoing the rapid change. Macro shifts and micro developments are combining to create a highly dynamic and more globalized health care industry than ever before.

Those who recognize and embrace these changes will be well placed to lead and make a real difference for patients and health care professionals. Of course, change is not new to Olympus. As an organization that is over 100 years old, we manifest a long history of successful adaptation

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot